title: The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies.
authors.affiliation: Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Selby
authors.forename: G
authors.initials: G
authors.lastname: Zulian
authors.forename: G
authors.initials: G
authors.lastname: Forgeson
authors.forename: A
authors.initials: A
authors.lastname: Nandi
authors.forename: S
authors.initials: S
authors.lastname: Milan
authors.forename: M
authors.initials: M
authors.lastname: Meldrum
authors.forename: C
authors.initials: C
authors.lastname: Viner
authors.forename: R
authors.initials: R
authors.lastname: Osborne
authors.forename: J S
authors.initials: JS
authors.lastname: Malpas
authors.forename: T J
authors.initials: TJ
authors.lastname: McElwain
mesh_terms: D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004739:England; D005500:Follow-Up Studies; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D014182:Transplantation, Autologous
chemical_list: D008558:Melphalan